HSKA : Summary for Heska Corporation - Yahoo Finance

U.S. Markets closed

Heska Corporation (HSKA)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
68.24-0.33 (-0.48%)
At close: 4:00 PM EST
People also watch:
ICCCANIKIARTCGENINSM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close68.57
Open68.86
Bid0.00 x
Ask0.00 x
Day's Range67.86 - 69.75
52 Week Range26.26 - 69.80
Volume50,247
Avg. Volume98,945
Market Cap470.72M
Beta0.51
PE Ratio (TTM)54.64
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is Heska Corp (HSKA) A Good Stock To Buy?
    Insider Monkey15 hours ago

    Is Heska Corp (HSKA) A Good Stock To Buy?

    The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentive to do the research necessary […]

  • AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
    Zacks4 days ago

    AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting

    AstraZeneca plc (AZN) presented positive data from a randomized phase III study (AURA3) on its lung cancer drug Tagrisso at a lung cancer conference in Vienna, Austria.

  • Juno Reports Positive Phase I Study Data on Lymphoma Drug
    Zacks4 days ago

    Juno Reports Positive Phase I Study Data on Lymphoma Drug

    Juno Therapeutics, Inc. (JUNO) announced encouraging preliminary clinical data from a phase I study (TRANSCEND) on its lead pipeline candidate, JCAR017, for the treatment of patients non-Hodgkin lymphoma (NHL).